VFA
SCLN

Virtus Fund Advisers’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Virtus Fund Advisers’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4,395
Closed -$23K – 2408
2014
Q2 		$23K Buy
+4,395
New +$21.4K ﹤0.01% 2370

Other funds holding SCLN

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
QBFM
QS Batterymarch Financial Management New York $3.78B AUM 22.02% 1-Year Est. Return

Virtus Fund Advisers's SCLN Position: Q3 2014 in Review

Virtus Fund Advisers sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q3 2014, closing a stake of 4,395 shares — an estimated $23K sold.

Virtus Fund Advisers first reported a position in SCLN in Q2 2014 and held it in 1 quarter. The position peaked at $23K in Q2 2014. 116 funds tracked by Wall St. Rank hold SCLN as of Q3 2014.

  • Virtus Fund Advisers reported no remaining Sciclone Pharmaceuticals Inc position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 4,395 Sciclone Pharmaceuticals Inc shares in Q3 2014, an estimated $23K.
  • Virtus Fund Advisers first reported a position in Sciclone Pharmaceuticals Inc in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's Sciclone Pharmaceuticals Inc position peaked at $23K in Q2 2014.
  • 116 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.